Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eaton Corporation plc (ETN) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

Eaton Corporation plcTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Eaton Corporation plc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Eaton Corporation plc trades at $425.19 (market cap $164.88B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.74 (market cap $25.27B). The key difference: Eaton Corporation plc is far larger — about 6.5× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

ETNRPRX
Market Cap
$164.88B$25.27B
Volume
2,535,0863,671,183
Sector
IndustrialsHealth
52-Week High
$459.96$63.96
52-Week Low
$315.82$35.44
Typical Hold Time
31 Days0 Days
Enterprise Value
$185.51B$32.50B
Dividend Yield
1.04%1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eaton Corporation plc

Eaton Corporation (ETN) trades at $424.64, down 1.55% today, with a bearish technical signal despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. ETN maintains robust profitability with 12.75% net income margin and 19.71% ROE, supported by strategic acquisitions in data center and aerospace markets. Recent news highlights growing investor attention and positive analyst coverage.

ETN presents a compelling growth story driven by data center demand and grid modernization, with 70% analyst buy ratings and a $502.38 consensus price target suggesting 18% upside. However, elevated valuation multiples (P/E 43.23) and bearish technical indicators warrant caution. Key risks include execution of acquisition strategy and competitive pressures in the electronics manufacturing sector.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ETN
73% Buy27% Sell
Avg holding period · 31 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Eaton Corporation plc

Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.

Read more on ETN →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →